¿ªÔÆÌåÓý

Dr. Thomas W. Martens is a board-certified staff internist at Park Nicollet Clinic in Minneapolis, MN, and serves as a medical director at the International Diabetes Center at Park Nicollet Clinic and ¿ªÔÆÌåÓý Care Group, as well as a research investigator at ¿ªÔÆÌåÓý Institute. In addition to maintaining an active internal medicine practice, he serves as principal investigator or co-investigator on a number of ongoing hybrid closed-loop insulin delivery studies, as well as studies involving the use of continuous glucose monitoring (CGM) technology in Type 2 diabetes. He is particularly interested in the translational aspects of implementing diabetes technology in a primary care setting and has presented locally and nationally on the use and interpretation of CGM data in primary care.

Dr. Martens attended medical school at the University of Wisconsin and completed an Internal Medicine residency and chief residency year at Hennepin County Medical Center in Minneapolis, MN.Ìý

Conducting Institute research since 2015.

Current positions:
Medical Director, International Diabetes Center
Research Investigator, ¿ªÔÆÌåÓý Institute
Consultant in Internal Medicine, Park Nicollet Clinic Brookdale Office

Education and training:Ìý
University of Wisconsin Medical School 2001
Residency in Internal Medicine, Hennepin County Medical Center 2005
Fellow of the American College of Physicians 2008

Affiliations/other offices held:
Consultant in Internal Medicine, Park Nicollet Clinic Brookdale Office
Attending physician, Methodist Hospital, St. Louis Park, Minnesota

Research interests include:
Clinical aspects of type 2 diabetes mellitus (T2D) management, quality improvement in the management of T2D. Translation and implementation of diabetes technology into clinical practice. Ambulatory Glucose Profile and continuous glucose monitor (CGM) based management of diabetes. Diabetes technology.

Current research activities and funding:
Principal investigator (PI) for the Patient Centered Outcomes Research Institute (PCORI)-fundedComparing Fingerstick Blood Glucose Monitoring versus Continuous Glucose Monitoring in Primary Care: The GluCoCare Study, which is evaluating the use of BGM and CGM based monitoring in the management of T2D for individuals using insulin to manage diabetes in primary care settings.

Principal Investigator: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People with T2 Diabetes. Funded by Abbott Diabetes Care.

Co-investigator of multiple industry-funded diabetes technology and medication trials evaluating hybrid closed-loop insulin delivery systems, new analog insulins, and analog insulin-GLP 1 RA medications.

Related websitesÌýÌý
;